Abricotis

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

calcium carbonate, Quantity: 1.5 g (Equivalent: calcium, Qty 600 mg); colecalciferol, Quantity: 0.0125 mg

Disponible depuis:

Pharmametics Products A Division of Max Biocare Pty Ltd

forme pharmaceutique:

Tablet, film coated

Composition:

Excipient Ingredients: colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; maltodextrin; microcrystalline cellulose; crospovidone; maize starch; Acacia; silicon dioxide; dl-alpha-tocopherol; sucrose; medium chain triglycerides; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black; purified water; strong ammonia solution; ethylcellulose; oleic acid

Mode d'administration:

Oral

indications thérapeutiques:

Maintain/support bone health ; Aids/assists healthy bone development/growth/building ; A diet deficient in calcium can lead to osteoporosis in later life. Calcium may help prevent osteoporosis when dietary intake is inadequate ; Vitamin D helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; Maintain/support muscle health ; Helps enhance/promote/increase absorption of dietary (state vitamin/mineral/nutrient) ; Maintain/support (state vitamin/mineral/nutrient) levels in the body ; Maintain/support healthy pregnancy

Descriptif du produit:

Visual Identification: ;

Statut de autorisation:

Listed

Date de l'autorisation:

2019-07-29